Gulf & Middle East · General news · Asharq Al-Awsat

AstraZeneca Says FDA Approves Drug for Rare Kidney Disease in Adults

Published by Asharq Al-Awsat · Saudi Arabia 16 h ago

AstraZeneca said on Wednesday the US Food and Drug Administration granted accelerated approval for its treatment for adults with immunoglobulin A nephropathy, a rare kidney…

Read the full article on Asharq Al-Awsat Sign in to save

MarketNews shows the headline and summary published by the outlet. The full article is on the publisher's website. (english.aawsat.com)

Also worth reading

Arab News

Israeli settlers steal Palestinians' olives as attacks on harvest grow more violent

Middle East Eye

Are we not allowed to say a genocide began on 7 October, too?

The Times of Israel

AstraZeneca Says FDA Approves Drug for Rare Kidney Disease in Adults

Share

Also worth reading

Taiwan issues warnings as Typhoon Champi nears

Bill Clinton quotes Quran and condemns anti-Muslim rhetoric

Gulf tour puts spring in Marcron's step to tackle protests at home

Israeli settlers steal Palestinians' olives as attacks on harvest grow more violent

Are we not allowed to say a genocide began on 7 October, too?

When Religion Becomes an Obstacle to Peace